B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

Damle RN, Ghiotto F, Valetto A, Albasiano E, Fais F, Yan XJ, Sison CP, Allen SL, Kolitz J, Schulman P, Vinciguerra VP, et al. (2002)
BLOOD 99(11): 4087-4093.

Download
No fulltext has been uploaded. References only!
Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Abstract
B-cell chronic lymphocytic leukemia (B-CLL) is considered an accumulative disease of antigen-naive CD5(+) B lymphocytes that circulate in the resting state. However, to evaluate the possibility that B-CLL cells resemble antigen-experienced and activated B cells, we analyzed the expression of markers of cellular activation and differentiation on CD5(+)CD19(+) cells from B-CLL patients and from age-matched healthy donors. The leukemic cells from all B-CLL patients, including those that lack significant numbers of V gene mutations, bear the phenotype of activated B cells based on the overexpression of the activation markers CD23, CD25, CD69, and CD71 and the underexpression of CD22, Fcgamma receptor IIb, CD79b, and immunoglobulin D that are down-regulated by cell triggering and activation. Furthermore, these leukemic cells resemble antigen-experienced lymphocytes in the underexpression of molecules that are down-regulated by cell triggering and in the uniform expression of CD27, an identifier of memory B cells. A comparison of the phenotypes of B-CLL patients with and without immunoglobulin V gene mutations suggests that the 2 subgroups differ both in specific marker expression (CD69, CD71, CD62 L, CD40, CD39, and HLA-DR) and in the time since antigenic stimulation, based on the reciprocal relationship of CD69 and CD71 expression. These findings imply that the leukemic cells from all B-CLL cases (irrespective of V gene mutations) exhibit features of activated and of antigen-experienced B lymphocytes and that the B-CLL cells that differ in immunoglobulin V genotype may have different antigen-encounter histories. (C) 2002 by The American Society of Hematology.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD. 2002;99(11):4087-4093.
Damle, R. N., Ghiotto, F., Valetto, A., Albasiano, E., Fais, F., Yan, X. J., Sison, C. P., et al. (2002). B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD, 99(11), 4087-4093. doi:10.1182/blood.V99.11.4087
Damle, R. N., Ghiotto, F., Valetto, A., Albasiano, E., Fais, F., Yan, X. J., Sison, C. P., Allen, S. L., Kolitz, J., Schulman, P., et al. (2002). B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD 99, 4087-4093.
Damle, R.N., et al., 2002. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD, 99(11), p 4087-4093.
R.N. Damle, et al., “B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes”, BLOOD, vol. 99, 2002, pp. 4087-4093.
Damle, R.N., Ghiotto, F., Valetto, A., Albasiano, E., Fais, F., Yan, X.J., Sison, C.P., Allen, S.L., Kolitz, J., Schulman, P., Vinciguerra, V.P., Budde, P., Frey, J., Rai, K.R., Ferrarini, M., Chiorazzi, N.: B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD. 99, 4087-4093 (2002).
Damle, RN, Ghiotto, F, Valetto, A, Albasiano, E, Fais, F, Yan, XJ, Sison, CP, Allen, SL, Kolitz, J, Schulman, P, Vinciguerra, VP, Budde, P, Frey, Jürgen, Rai, KR, Ferrarini, M, and Chiorazzi, N. “B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes”. BLOOD 99.11 (2002): 4087-4093.
This data publication is cited in the following publications:
This publication cites the following data publications:

162 Citations in Europe PMC

Data provided by Europe PubMed Central.

Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.
Vilpo J, Tobin G, Hulkkonen J, Hurme M, Thunberg U, Sundström C, Vilpo L, Rosenquist R., Eur J Haematol 70(1), 2003
PMID: 12631259
Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia.
D'Arena G, Di Renzo N, Brugiatelli M, Vigliotti ML, Keating MJ., Leuk Lymphoma 44(2), 2003
PMID: 12688337
DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia.
Frankel AE, Fleming DR, Powell BL, Gartenhaus R., Expert Opin Biol Ther 3(1), 2003
PMID: 12718740
Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype.
Segel GB, Woodlock TJ, Xu J, Li L, Felgar RE, Ryan DH, Lichtman MA, Wang N., Blood Cells Mol Dis 30(3), 2003
PMID: 12737946
Human peripheral B cells: a different cytometric point of view.
Carbonari M, Tedesco T, Fiorilli M., Cytometry A 53(2), 2003
PMID: 12766971
Immunobiology of chronic lymphocytic leukemia.
Kipps TJ., Curr Opin Hematol 10(4), 2003
PMID: 12799538
Towards molecular diagnosis and targeted therapy of lymphoid malignancies.
Wiestner A, Staudt LM., Semin Hematol 40(4), 2003
PMID: 14582080
Role of the microenvironment in chronic lymphocytic leukaemia.
Caligaris-Cappio F., Br J Haematol 123(3), 2003
PMID: 14616995
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.
Gurrieri C, McGuire P, Zan H, Yan XJ, Cerutti A, Albesiano E, Allen SL, Vinciguerra V, Rai KR, Ferrarini M, Casali P, Chiorazzi N., J Exp Med 196(5), 2002
PMID: 12208878
Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells.
Cerutti A, Zan H, Kim EC, Shah S, Schattner EJ, Schaffer A, Casali P., J Immunol 169(11), 2002
PMID: 12444172
Do CLL B cells correspond to naive or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells.
Oppezzo P, Magnac C, Bianchi S, Vuillier F, Tiscornia A, Dumas G, Payelle-Brogard B, Ajchenbaum-Cymbalista F, Dighiero G, Pritsch O., Leukemia 16(12), 2002
PMID: 12454750

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 12010811
PubMed | Europe PMC

Search this title in

Google Scholar